down yes but hopefully those selling are the ones who were hoping for a quick exit after a jump in the share price. From my reading of things this drug still has a place as more and more of those on the market now, develop resistance.
I'd still like to know what the retention rate is for those who were in the trials. Are they allowed to keep taking it? And if so, do those results count?
